As of 3:59pm ET
| -0.02 / -0.26%|
The 3 analysts offering 12-month price forecasts for Organogenesis Holdings Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 10.00. The median estimate represents a +45.12% increase from the last price of 7.58.
The current consensus among 3 polled investment analysts is to Buy stock in Organogenesis Holdings Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.